Close Menu

All of the Dots

The New York Times profiles Eric Schadt, the chief scientific officer of Pacific Biosciences, from his days in the Air Force to working with his new nonprofit, Sage Bionetworks. In the article Schadt is heralded for his unconventional approach — both to his research and attire. The new venture, Sage, has received data and hardware from Merck's Rosetta subsidiary, where Schadt worked until recently.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.